BioSpace News Archive

This license is issued by Health Canada under the authority of the Natural Health Products Regulations.

This is CTD’s fourth year of supporting the conference with an unrestricted grant and in presenting on the company’s clinical program in Niemann-Pick Disease Type C (NPC).

The virtual health village will eliminate friction across all aspects of the healthcare continuum and serve as an engaging, singular space where patients and families can access virtual care, view and update health information, participate in social communities, communicate with providers, receive reminders, schedule appointments and more.

Liver Transplantation Is on the Rise - World Hepatitis Day, July 28, Gives Cause to Celebrate Advancements

Canon Medical’s Alphenix family of interventional systems was debuted during the conference’s 11th annual Innovation Celebration, an event recognizing advancements in healthcare and highlighting suppliers dedicated to furthering innovation and improving patient outcomes in the industry.

Advancing Eyecare announced the acquisition of Ophthalmic Instruments & Consulting Company, the leading expert and supplier of classical and diagnostic equipment in the Pacific Northwest.

Now that the National Ecological Observatory Network is operational, the continental-sized network funded by the National Science Foundation and operated by Battelle can fulfill its mission: Provide free, high-quality, standardized ecological data for scientists around the world to use for important research projects.

The National Council on Compensation Insurance (NCCI) released its 2019 Regulatory and Legislative Trends Report

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the New Zebron™ Gas Management Filters and Click-on Inline Gas Trap, which removes contaminants from carrier gas to reduce gas chromatography system downtime and column damage and deliver pure gas for maximum analytical sensitivity.

Sensorion a pioneering clinical-stage biopharmaceutical company which specialises in the development of novel therapies to restore, treat and prevent inner ear diseases such as hearing loss, tinnitus and vertigo held its combined general meeting on July 29, 2019.